Roche with­draws EMA ex­pan­sion ap­pli­ca­tion for can­cer med­i­cine Gazy­varo af­ter lack of 'ro­bust' tri­al meth­ods

Roche pulled its mar­ket­ing au­tho­riza­tion ap­pli­ca­tion with the Eu­ro­pean Med­i­cines Agency (EMA) ear­li­er this month to ex­pand the la­bel for its can­cer med­i­cine Gazy­varo, be­cause …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER